Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PWR | CME |
|---|---|---|
| Price | $643.02 | $269.03 |
| Change today | ▲ 1.28% | ▼ 0.65% |
| Market cap | $96.67B | $96.74B |
| Return, 3 months | -8.4% | +16.7% |
| Return, year to date | +52.4% | +1.9% |
| Return, 1 year | +59.7% | +5.7% |
| P/E (TTM) | 73.6 | 22.8 |
| P/B | 10.0 | 3.6 |
| P/E percentile vs own 5y | 88th | 12th |
| Dividend yield | 0.07% | 4.18% |
| Revenue growth (YoY, latest qtr) | +41.1% | +0.8% |
| Net profit growth (YoY) | +96.8% | +1.6% |
| Gross margin | 15.5% | 86.2% |
| Operating margin | 6.1% | 65.1% |
| Net margin | 4.0% | 63.0% |
| Return on equity | 15.2% | 15.7% |
| Analyst target vs. price | +24.0% | +3.5% |
| Analyst buy share | 80% | 40% |
| RSI (14) | 50 | 51 |
| 30-day volatility | 39.3% | 23.3% |
| Max drawdown, 1 year | -28.5% | -31.1% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.